Stay updated on Safe Doses CX-2029 in Solid Tumors and DLBCL Clinical Trial

Sign up to get notified when there's something new on the Safe Doses CX-2029 in Solid Tumors and DLBCL Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safe Doses CX-2029 in Solid Tumors and DLBCL Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The two screenshots show the same study page with only minor layout adjustments and an updated last-updated timestamp; there are no changes to eligibility criteria, primary or secondary outcomes, enrollment, or study status. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-10-27T20:54:36.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    Added a government-status notice, confirmed NIH Clinical Center is open, added new condition 'Malignant lymphoma, large B-cell, diffuse' and revision v3.2.0; removed 'Carcinoma of esophagus' and revision v3.1.0.
    Difference
    5%
    Check dated 2025-10-06T07:51:17.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    Version upgraded to v3.1.0 with removal of the term 'Diffuse large b-cell lymphoma'.
    Difference
    0.3%
    Check dated 2025-09-29T04:11:34.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    Updated to Revision v3.0.2; removed Back to Top link.
    Difference
    0.3%
    Check dated 2025-09-14T21:42:03.000Z thumbnail image
  7. Check
    52 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.
    Difference
    0.3%
    Check dated 2025-09-07T17:59:45.000Z thumbnail image
  8. Check
    60 days ago
    Change Detected
    Summary
    The web page has added significant information regarding cancer-related topics and resources, including specific types of tumors and their implications, while also updating the facility name and location details. Notably, some previously listed resources and location terms have been removed.
    Difference
    8%
    Check dated 2025-08-31T12:17:57.000Z thumbnail image

Stay in the know with updates to Safe Doses CX-2029 in Solid Tumors and DLBCL Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safe Doses CX-2029 in Solid Tumors and DLBCL Clinical Trial page.